Evidence map›Paper›PMID 8168832›Full record

ArticleHuman genetics1994

Ancestry of SINE-R.C2 a human-specific retroposon.

Z B Zhu, B Jian, J E Volanakis

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Human genetics, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Z B ZhuDepartment of Medicine, University of Alabama at Birmingham 35294.
B Jian
J E Volanakis
University of Alabama at Birmingham · US

Funding

TISSUE-SPECIFIC ANTIGEN RECEPTOR REPERTOIRES IN RAP01AR003555 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 1986 to 1995
–
ASSEMBLY AND REGULATION OF COMPLEMENT C3-CONVERTASESR01AI021067 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHU, ZENG B · 1985 to 1998
–
NIAID NIH HHS AI21067NIAMS NIH HHS AR03555
6 · The paper itself

Abstract

We have reported previously that a retroposon, containing a variable number of tandemly repeated nucleotide sequences, is present in the third intron of the human C2 gene. This element, termed SINE-R.C2, is a member of a large retroposon family derived from the endogenous retrovirus HERV-K10 and estimated to include a few thousand copies per haploid human genome. In the present study we analyzed genomic DNA from 175 humans from several ethnic groups including Americans of European and African descent, Chinese, Africans, Australians, Pacific Islanders, Japanese, and Koreans. They all contained SINE-R.C2, as indicated by Southern blotting. However, SINE-R.C2 was absent from the genome of nonhuman primates, although SINE-R-type elements were present in chimpanzees and gorillas and the HERV-K10 genome was apparently present in all primates except for New World monkeys. These results indicate that HERV-K10 was inserted into the genome after the divergence of New World monkeys; the prototype SINE-R element, after divergence of orangutans; and SINE-R.C2, after the split between humans and chimpanzees.

Indexed as

DNA Transposable ElementsAnimalsBase SequenceBiological EvolutionBlotting, SouthernComplement C2DNADNA PrimersEthnicityGenetic VariationHumansMammary Tumor Virus, MouseMolecular Sequence DataPrimatesRetroviridaeComplement C2DNADNA PrimersDNA Transposable Elements

Identifiers

PMID8168832
OpenAlexW1976492123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.